What happened
Biodyne reported consolidated results for FY2025: revenue of US$4.85M (+33.4% year on year), operating profit of US$261K (from a loss a year earlier) and net income of US$638K (+8482.5% year on year).
Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.
| Revenue | US$4.85M |
|---|---|
| Revenue vs a year earlier | +33.4% |
| Operating profit | US$261K |
| Net income | US$638K |
| Period | FY2025 (consolidated) |
| Filed | 2026-02-02, Change of 30% or more in revenue or profit/loss structure (15% for large companies) |
| Source | DART rcept 20260202900302 → open original filing |
Source: DART. Information only, not investment advice.